Related Experiment Video

Updated: Mar 28, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.4K

Diagnosis and management of hypertrophic cardiomyopathy

Antonis Pantazis1, Annina S Vischer1, Maria Carrillo Perez-Tome1

  • 1The Heart Hospital , 16-18 Westmoreland Street, London, W1G 8PH , UK.

Echo Research and Practice
|December 23, 2015
PubMed

Insights

Hypertrophic cardiomyopathy (HCM) presents diverse symptoms and risks, including arrhythmias and sudden cardiac death (SCD). Effective diagnosis and management aim to alleviate symptoms and prevent severe complications for patients.

Area of Science:

  • Cardiology
  • Genetics
  • Internal Medicine

Background:

  • Hypertrophic cardiomyopathy (HCM) exhibits a complex clinical spectrum with varied phenotypes and manifestations.
  • While many patients are asymptomatic, a significant portion face risks of arrhythmias and sudden cardiac death (SCD).

Purpose of the Study:

  • To outline the diagnostic and management objectives for hypertrophic cardiomyopathy.
  • To address the challenges cardiologists face due to the heterogeneity of HCM patterns, symptoms, and assessment.

Main Methods:

  • Review of clinical spectrum and phenotypes of hypertrophic cardiomyopathy.
  • Analysis of diagnostic and management strategies for HCM.
  • Discussion of challenges in assessing HCM heterogeneity.

Main Results:

  • HCM presents diverse phenotypes, leading to varied clinical manifestations.
  • Key objectives include symptom relief, prevention of disease progression, and mitigation of SCD risk.
  • The heterogeneity of HCM poses significant challenges for accurate diagnosis and effective management.

Conclusions:

  • Comprehensive understanding and tailored management strategies are crucial for addressing the complexity of hypertrophic cardiomyopathy.
  • Addressing diagnostic and assessment challenges is vital for improving patient outcomes in HCM.

Keywords:
Anderson-Fabry's diseaseFriedreich's ataxiaamyloidosiscardiac magnetic resonance imaginghypertrophic cardiomyopathyleft ventricular outflow tract obstruction

More Related Videos

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

6.3K
Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples14:39

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples

Published on: April 21, 2014

18.1K

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
697
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
634
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
751
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
809
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
319
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
800